EOS301984
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EOS301984, covering 2025-08-13 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors [Phase 1]